Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1654 1675
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17286857 | Netrin-1 Compounds and Compositions Thereof for Treating Pulmonary Hypertension | Final Rejection | The Regents of the University of California |
| 18030250 | COMPOSITIONS AND METHODS OF TREATING A PI3K MEDIATED DISEASE | Non-Final OA | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. |
| 17631934 | AGENT FOR PREVENTING OR TREATING MILD COGNITIVE IMPAIRMENT | Non-Final OA | NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY |
| 18045317 | Antagonism of the VIP Signaling Pathway | Non-Final OA | Emory University |
| 17631820 | MHC CLASS II MOLECULES AND METHODS OF USE THEREOF | Non-Final OA | University Health Network |
| 17629338 | A SERIES OF INJECTABLE HYDROGELS SELF-ASSEMBLED FROM SHORT PEPTIDES FOR VARIOUS BIOMEDICAL APPLICATIONS | Non-Final OA | Agency for Science, Technology and Research |
| 17290264 | Native whey protein for improving intestinal maturation | Non-Final OA | N.V. Nutricia |
| 17312296 | AMINO ACID HAVING FUNCTIONAL GROUP CAPABLE OF INTERMOLECULAR HYDROGEN BONDING, PEPTIDE COMPOUND CONTAINING SAME AND METHOD FOR PRODUCTION THEREOF | Final Rejection | Chugai Seiyaku Kabushiki Kaisha |
| 18602513 | COMPOSITIONS AND METHOD FOR OPTIMIZED PEPTIDE VACCINES USING RESIDUE OPTIMIZATION | Non-Final OA | Think Therapeutics, Inc. |
| 18004233 | COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS | Non-Final OA | GRIFOLS WORLDWIDE OPERATIONS LIMITED |
| 18352101 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF WOUNDS | Non-Final OA | Imperial College Innovations Limited |
| 18136803 | Sialylated Glycoproteins | Final Rejection | Momenta Pharmaceuticals, Inc. |
| 17309626 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP | Final Rejection | BicycleTx Limited |
| 17633836 | STABILIZING BUFFER FOR FACTOR VIII AND VWF | Final Rejection | OCTAPHARMA AG |
| 18006110 | ECHINOCANDIN DRUG IMPURITY, AND PREPARATION AND PURIFICATION METHODS AND USE THEREOF | Non-Final OA | Shanghai Techwell Biopharmaceutical Co., Ltd |
| 18016855 | STABLE FORMULATIONS OF ANTI-CANCER PEPTIDES | Non-Final OA | Oncolyze, Inc. |
| 18003123 | FUSION PROTEIN COMPRISING ANTI-LAG-3 ANTIBODY AND IL-2, AND USE THEREOF | Non-Final OA | GI INNOVATION, INC. |
| 18058112 | SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE | Non-Final OA | VIVEX BIOLOGICS GROUP, INC |
| 17416845 | NOVEL COMPOSITION | Non-Final OA | ARECOR LIMITED |
| 17915812 | POLYPEPTIDE FOR THE PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS | Non-Final OA | PHARIS BIOTEC GMBH |
| 17827832 | CXCR4 INHIBITOR FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND VIRAL INFECTIONS | Non-Final OA | BioLineRx Ltd. |
| 17777567 | POLYPEPTIDE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Final Rejection | SHANXI JINBO BIO-PHARMACEUTICAL CO., LTD. |
| 17624690 | COMBINATION | Non-Final OA | GENESIS PHARMA SA |
| 17614533 | COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY | Non-Final OA | Nano-Neo Ltd. |
| 17089220 | COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF SKIN DISEASES AND DISORDERS WITH LEKTI | Non-Final OA | Azitra Inc |
| 15749275 | CNP CYCLIC PEPTIDE, AND MEDICINE, EXTERNAL PREPARATION AND COSMETIC EACH CONTAINING SAID CYCLIC PEPTIDE | Non-Final OA | IGISU Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy